back to publications

2024 PUBLICATIONS:

  • Loh KM, Zheng SL, Liu KJ, Yin Q, Amir-Ugokwe ZA, Jha SK, Qi Y, Wazny VK, Nguyen AT, Chen A, Cheung C, Spiekerkoetter E, Red-Horse K, Ang LT (2024). Protocol for efficient generation of human artery and vein endothelial cells from pluripotent stem cells. STAR Protocols 6: 103494.

  • Wu X, Chen PI, Whitener RL, MacDougall MS, Coykendall VMN, Yan H, Kim YB, Harper W, Pathak S, Iliopoulou BP, Hestor A, Saunders DC, Spears E, Sévigny J, Maahs DM, Basina M, Sharp SA, Gloyn AL, Powers AC, Kim SK, Jensen KP, Meyer EH. CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets. 2024. Front Immunol. 15:1415102. doi: 10.3389/fimmu.2024.1415102. PMID: 39007132.

  • Chamberlain CE, German MS, Philipson LH, Anderson MS. Monogenic Type 1 Diabetes: A High Yield Pool in Which to Discover New Mechanisms and Candidate Therapeutics for Type 1 Diabetes. Cold Spring Harbor Perspectives in Medicine. 2024 Dec 18:a041601.

  • Reddy NR, Maachi H, Xiao Y, Simic MS, Yu W, Tonai Y, Cabanillas DA, Serrano-Wu E, Pauerstein PT, Tamaki W, Allen GM, Parent AV, Hebrok M, Lim WA. Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs. Science. 2024 Dec 6;386(6726):eadl4793.